XTLB logo

XTL Biopharmaceuticals (XTLB) Net Income

Annual Net Income

-$1.78 M
-$434.00 K-32.20%

December 31, 2023

Summary

Performance

1-Year Change

-32.2%

3-Year Change

+39.68%

5-Year Change

-149.09%

15-Year Change

-128.17%

XTLB Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.16%
XTLB annual net profit is higher than 82.16% of companies in Healthcare sector

High & Low

All-time High

$3.63 M
XTLB annual net profit is currently -149.09% below its historical high of $3.63 million

3-Year Low

-$1.78 M
XTLB annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
XTLB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 30, 2025
XTLB next annual earnings announcement is scheduled for Apr 30, 2025

OtherXTLBprofitabilitymetrics:

Annual Net Margin

-
XTLB annual net profit margin value is unknown

Annual Revenue

-
XTLB annual revenue value is unknown

Annual Gross Profit

-
XTLB annual gross profit value is unknown

Annual EPS

-$0.30
XTLB annual earnings per share is -$0.30

Quarterly Net Income

-$553.00 K
+$151.00 K+21.45%

September 30, 2024

Summary

Performance

3-Month Change

+21.45%

1-Year Change

-214.02%

3-Year Change

-214.02%

5-Year Change

+41.54%

XTLB Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.28%
XTLB quarterly net profit is higher than 78.28% of companies in Healthcare sector

High & Low

All-time High

$3.87 M
XTLB quarterly net profit is currently -114.27% below its historical high of $3.87 million

3-Year Low

-$919.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XTLB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
XTLB next earnings announcement is scheduled for Apr 30, 2025

OtherXTLBprofitabilitymetrics:

Quarterly Net Margin

-341.36%
XTLB quarterly net profit margin is -341.36%

Quarterly Revenue

$162.00 K
XTLB quarterly revenue is $162.00 thousand

Quarterly Gross Profit

-
XTLB quarterly gross profit value is unknown

Quarterly EPS

-$0.16
XTLB quarterly earnings per share is -$0.16

TTM Net Income

-$1.06 M
-$338.00 K-47.08%

September 30, 2024

Summary

Performance

3-Month Change

-47.08%

1-Year Change

-179.37%

3-Year Change

-179.37%

5-Year Change

+56.07%

XTLB TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.87%
XTLB TTM net profit is higher than 81.87% of companies in Healthcare sector

High & Low

All-time High

$6.63 M
XTLB TTM net profit is currently -115.93% below its historical high of $6.63 million

3-Year Low

-$2.85 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XTLB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
XTLB next earnings announcement is scheduled for Apr 30, 2025

OtherXTLBprofitabilitymetrics:

Annual Net Margin

-
XTLB annual net profit margin value is unknown

TTM Revenue

$162.00 K
XTLB TTM revenue is $162.00 thousand

TTM Gross Profit

-
XTLB TTM gross profit value is unknown

TTM EPS

-$0.20
XTLB TTM earnings per share is -$0.20

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$1.78 M
XTLB annual net profit is -$1.78 million

Annual Revenue

-
XTLB annual revenue value is unknown

Annual Cost Of Goods Sold

-
XTLB annual cost of goods sold value is unknown

Annual Operating Expenses

$765.00 K
XTLB annual total operating expenses is $765.00 thousand

Annual Interest Expense

-
XTLB annual interest expense value is unknown

Annual Income Tax

-
XTLB annual income tax value is unknown

XTLB Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.2%-214.0%-179.4%
3 y3 years+39.7%-214.0%-179.4%
5 y5 years-149.1%+41.5%+56.1%

XTLB Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-509.7%at low-126.4%+39.8%-169.4%+63.0%
5 y5-year-509.7%+39.7%-126.4%+51.9%-169.4%+76.3%
alltimeall time-149.1%+92.8%-114.3%+93.4%-115.9%+95.7%

XTL Biopharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$553.00 K(-21.4%)
-$1.06 M(+47.1%)
Jun 2024
-
-$704.00 K(-245.2%)
-$718.00 K(+89.9%)
Mar 2024
-
$485.00 K(-270.8%)
-$378.00 K(-78.8%)
Dec 2023
-$1.78 M(+32.2%)
-$284.00 K(+32.1%)
-$1.78 M(-20.7%)
Sep 2023
-
-$215.00 K(-40.9%)
-$2.25 M(-21.2%)
Jun 2023
-
-$364.00 K(-60.4%)
-$2.85 M(+2.8%)
Mar 2023
-
-$919.00 K(+22.9%)
-$2.77 M(+105.7%)
Dec 2022
-$1.35 M(-409.9%)
-$748.00 K(-8.9%)
-$1.35 M(-190.2%)
Sep 2022
-
-$821.00 K(+188.1%)
$1.50 M(-1.7%)
Jun 2022
-
-$285.00 K(-156.3%)
$1.52 M(+131.9%)
Mar 2022
-
$506.00 K(-75.8%)
$656.00 K(+50.5%)
Dec 2021
$435.00 K(-114.7%)
$2.10 M(-363.5%)
$436.00 K(-115.9%)
Sep 2021
-
-$795.00 K(-30.9%)
-$2.73 M(-5.2%)
Jun 2021
-
-$1.15 M(-502.1%)
-$2.89 M(+1.6%)
Mar 2021
-
$286.00 K(-126.6%)
-$2.84 M(-3.8%)
Dec 2020
-$2.95 M(+287.2%)
-$1.08 M(+13.7%)
-$2.95 M(+22.9%)
Sep 2020
-
-$946.00 K(-14.4%)
-$2.40 M(-11.5%)
Jun 2020
-
-$1.10 M(-738.7%)
-$2.71 M(-39.2%)
Mar 2020
-
$173.00 K(-132.9%)
-$4.46 M(+485.1%)
Dec 2019
-$763.00 K(-121.0%)
-$526.00 K(-58.2%)
-$763.00 K(-152.5%)
Sep 2019
-
-$1.26 M(-56.0%)
$1.45 M(-61.1%)
Jun 2019
-
-$2.85 M(-173.7%)
$3.74 M(-43.6%)
Mar 2019
-
$3.87 M(+129.1%)
$6.63 M(+82.6%)
Dec 2018
$3.63 M(-564.8%)
$1.69 M(+64.2%)
$3.63 M(+87.4%)
Sep 2018
-
$1.03 M(+2929.4%)
$1.94 M(-22.3%)
Jun 2018
-
$34.00 K(-96.1%)
$2.49 M(+132.8%)
Mar 2018
-
$875.00 K(<-9900.0%)
$1.07 M(-237.1%)
Dec 2017
-$781.00 K(-69.3%)
-$2000.00(-100.1%)
-$781.00 K(-60.6%)
Sep 2017
-
$1.59 M(-214.3%)
-$1.98 M(-48.5%)
Jun 2017
-
-$1.39 M(+42.1%)
-$3.86 M(+30.9%)
Mar 2017
-
-$977.00 K(-18.9%)
-$2.94 M(+15.7%)
Dec 2016
-$2.54 M(-41.0%)
-$1.21 M(+321.3%)
-$2.54 M(-31.3%)
Sep 2016
-
-$286.00 K(-40.0%)
-$3.71 M(-4.1%)
Jun 2016
-
-$477.00 K(-17.3%)
-$3.86 M(+1.3%)
Mar 2016
-
-$577.00 K(-75.6%)
-$3.81 M(-11.6%)
Dec 2015
-$4.31 M(+50.5%)
-$2.37 M(+433.9%)
-$4.31 M(+41.3%)
Sep 2015
-
-$443.00 K(+3.7%)
-$3.05 M(-2.1%)
Jun 2015
-
-$427.00 K(-60.3%)
-$3.12 M(-4.2%)
Mar 2015
-
-$1.08 M(-2.7%)
-$3.25 M(+13.6%)
Dec 2014
-$2.87 M(-22.8%)
-$1.11 M(+116.9%)
-$2.87 M(-30.9%)
Sep 2014
-
-$510.00 K(-9.4%)
-$4.15 M(+34.3%)
Jun 2014
-
-$563.00 K(-17.9%)
-$3.09 M(-12.5%)
Mar 2014
-
-$686.00 K(-71.3%)
-$3.53 M(-5.0%)
DateAnnualQuarterlyTTM
Dec 2013
-$3.71 M(+167.1%)
-$2.39 M(-534.8%)
-$3.71 M(+128.9%)
Sep 2013
-
$549.00 K(-154.7%)
-$1.62 M(-27.0%)
Jun 2013
-
-$1.00 M(+15.0%)
-$2.22 M(+17.3%)
Mar 2013
-
-$872.00 K(+194.6%)
-$1.89 M(+36.2%)
Dec 2012
-$1.39 M(+15.2%)
-$296.00 K(+492.0%)
-$1.39 M(+0.6%)
Sep 2012
-
-$50.00 K(-92.6%)
-$1.38 M(-17.2%)
Jun 2012
-
-$675.00 K(+82.9%)
-$1.67 M(+31.0%)
Mar 2012
-
-$369.00 K(+28.1%)
-$1.27 M(+5.6%)
Dec 2011
-$1.21 M(-4.0%)
-$288.00 K(-14.5%)
-$1.21 M(-2.2%)
Sep 2011
-
-$337.00 K(+20.4%)
-$1.23 M(+4.0%)
Jun 2011
-
-$280.00 K(-7.3%)
-$1.19 M(-2.9%)
Mar 2011
-
-$302.00 K(-4.1%)
-$1.22 M(-2.7%)
Dec 2010
-$1.26 M(-148.6%)
-$315.00 K(+8.6%)
-$1.26 M(+2.2%)
Sep 2010
-
-$290.00 K(-8.2%)
-$1.23 M(+32.1%)
Jun 2010
-
-$316.00 K(-6.0%)
-$931.00 K(-255.7%)
Mar 2010
-
-$336.00 K(+16.7%)
$598.00 K(-76.9%)
Dec 2009
$2.59 M(-114.0%)
-$288.00 K(-3300.0%)
$2.59 M(-147.0%)
Sep 2009
-
$9000.00(-99.3%)
-$5.50 M(-18.6%)
Jun 2009
-
$1.21 M(-26.6%)
-$6.76 M(-41.4%)
Mar 2009
-
$1.65 M(-119.7%)
-$11.54 M(-31.1%)
Dec 2008
-$18.43 M(-26.1%)
-$8.38 M(+569.9%)
-$16.75 M(+100.2%)
Sep 2008
-
-$1.25 M(-64.8%)
-$8.37 M(-37.3%)
Jun 2008
-
-$3.56 M(-0.0%)
-$13.35 M(-22.0%)
Mar 2008
-
-$3.56 M(<-9900.0%)
-$17.12 M(-18.0%)
Dec 2007
-$24.94 M(+64.8%)
$0.00(-100.0%)
-$20.88 M(-15.8%)
Sep 2007
-
-$6.23 M(-14.9%)
-$24.80 M(+10.3%)
Jun 2007
-
-$7.33 M(0.0%)
-$22.49 M(+19.6%)
Mar 2007
-
-$7.33 M(+86.9%)
-$18.81 M(+24.3%)
Dec 2006
-$15.13 M(+8.0%)
-$3.92 M(-0.0%)
-$15.13 M(-3.9%)
Sep 2006
-
-$3.92 M(+7.5%)
-$15.74 M(-3.7%)
Jun 2006
-
-$3.65 M(0.0%)
-$16.35 M(+7.7%)
Mar 2006
-
-$3.65 M(-19.5%)
-$15.18 M(+8.3%)
Dec 2005
-$14.02 M(-14.9%)
-$4.53 M(-0.0%)
-$14.02 M(+3.0%)
Sep 2005
-
-$4.53 M(+82.9%)
-$13.60 M(+3.1%)
Jun 2005
-
-$2.48 M(0.0%)
-$13.19 M(-16.2%)
Mar 2005
-
-$2.48 M(-39.9%)
-$15.75 M(-9.4%)
Dec 2004
-$16.47 M(+15.3%)
-$4.12 M(+0.0%)
-$17.39 M(+31.0%)
Sep 2004
-
-$4.12 M(-18.2%)
-$13.27 M(+45.0%)
Jun 2004
-
-$5.03 M(+22.2%)
-$9.15 M(+122.2%)
Mar 2004
-
-$4.12 M
-$4.12 M
Dec 2003
-$14.29 M(-16.6%)
-
-
Dec 2002
-$17.14 M(+35.2%)
-
-
Dec 2001
-$12.67 M
-
-

FAQ

  • What is XTL Biopharmaceuticals annual net profit?
  • What is the all time high annual net income for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals annual net income year-on-year change?
  • What is XTL Biopharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals quarterly net income year-on-year change?
  • What is XTL Biopharmaceuticals TTM net profit?
  • What is the all time high TTM net income for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals TTM net income year-on-year change?

What is XTL Biopharmaceuticals annual net profit?

The current annual net income of XTLB is -$1.78 M

What is the all time high annual net income for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high annual net profit is $3.63 M

What is XTL Biopharmaceuticals annual net income year-on-year change?

Over the past year, XTLB annual net profit has changed by -$434.00 K (-32.20%)

What is XTL Biopharmaceuticals quarterly net profit?

The current quarterly net income of XTLB is -$553.00 K

What is the all time high quarterly net income for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high quarterly net profit is $3.87 M

What is XTL Biopharmaceuticals quarterly net income year-on-year change?

Over the past year, XTLB quarterly net profit has changed by -$1.04 M (-214.02%)

What is XTL Biopharmaceuticals TTM net profit?

The current TTM net income of XTLB is -$1.06 M

What is the all time high TTM net income for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high TTM net profit is $6.63 M

What is XTL Biopharmaceuticals TTM net income year-on-year change?

Over the past year, XTLB TTM net profit has changed by -$678.00 K (-179.37%)